Tumour necrosis factor-alpha but not interleukin-1 induces polymorphonuclear leucocyte migration through fibroblast layers by a fibroblast-dependent mechanism.

Por Morzycki, W, Issekutz, A C
Publicado em 1991

A personalized approach to treatment: use of egfr tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada

Por Hirsh, V., Melosky, B., Goss, G., Morris, D., Morzycki, W.
Publicado em 2012

Corrigendum: A personalized approach to treatment: use of egfr tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada

Por Hirsh, V., Melosky, B., Goss, G., Morris, D., Morzycki, W.
Publicado em 2012

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national conse...

Por Ellis, P.M., Morzycki, W., Melosky, B., Butts, C., Hirsh, V., Krasnoshtein, F., Murray, N., Shepherd, F.A., Soulieres, D., Tsao, M.S., Goss, G.
Publicado em 2009

Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer

Por Melosky, B., Agulnik, J., Albadine, R., Banerji, S., Bebb, D.G., Bethune, D., Blais, N., Butts, C., Cheema, P., Cheung, P., Cohen, V., Deschenes, J., Ionescu, D.N., Juergens, R., Kamel-Reid, S., Laurie, S.A., Liu, G., Morzycki, W., Tsao, M.S., Xu, Z., Hirsh, V.
Publicado no Curr Oncol (2016)